AnaptysBio Inc buy Wells Fargo & Company
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€38.17
Performance (%)
159.72%
End price
13.12.25
€37.40
Summary
This prediction ended on 13.12.25 with a price of €37.40. The BUY prediction by Wells_Fargo___Compan for AnaptysBio Inc saw massive gains of 159.72%. Wells_Fargo___Compan has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 4.061% | 4.061% | 138.372% |
| iShares Core DAX® | 0.170% | 2.184% | 15.013% |
| iShares Nasdaq 100 | 0.515% | 0.370% | 6.226% |
| iShares Nikkei 225® | 1.614% | 6.357% | 21.242% |
| iShares S&P 500 | -0.719% | -0.275% | 1.451% |
Comments by Wells_Fargo___Compan for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten